NICORETTE nicotine 2 mg (as nicotine Polacrilex) icy mint flavour chewing gum pocket pack Australia - English - Department of Health (Therapeutic Goods Administration)

nicorette nicotine 2 mg (as nicotine polacrilex) icy mint flavour chewing gum pocket pack

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg - gum, chewing - excipient ingredients: xylitol; peppermint oil; acesulfame potassium; sodium bicarbonate; hypromellose; pregelatinised maize starch; carnauba wax; sodium carbonate; light magnesium oxide; titanium dioxide; polysorbate 80; sucralose; menthol; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

NICORETTE nicotine 4mg (as nicotine polacrilex) spearmint flavour chewing gum blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

nicorette nicotine 4mg (as nicotine polacrilex) spearmint flavour chewing gum blister pack

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg - gum, chewing - excipient ingredients: hypromellose; quinoline yellow aluminium lake; xylitol; acacia; carnauba wax; acesulfame potassium; polysorbate 80; menthol; light magnesium oxide; sodium carbonate; titanium dioxide; peppermint oil; sucralose; flavour; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

NICORETTE nicotine 2mg (as nicotine polacrilex) spearmint flavour chewing gum blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

nicorette nicotine 2mg (as nicotine polacrilex) spearmint flavour chewing gum blister pack

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 10 mg - gum, chewing - excipient ingredients: hypromellose; acesulfame potassium; peppermint oil; xylitol; polysorbate 80; acacia; titanium dioxide; carnauba wax; sucralose; menthol; sodium carbonate; sodium bicarbonate; light magnesium oxide; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; flavour - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

NICABATE MINI LOZENGES nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation) Australia - English - Department of Health (Therapeutic Goods Administration)

nicabate mini lozenges nicotine 4 mg (as polacrilex) mint flavour lozenge tube (new formulation)

haleon australia pty ltd - nicotine polacrilex, quantity: 20 mg (equivalent: nicotine, qty 4 mg) - lozenge - excipient ingredients: sucralose; sodium carbonate; sodium bicarbonate; mannitol; magnesium stearate; hypromellose; xanthan gum; indigo carmine aluminium lake; acesulfame potassium; microcrystalline cellulose; crospovidone; xylitol; calcium hydrogen phosphate; flavour - for the relief of nicotine withdrawal symptoms including cravings associated with smoking cessation. it may also be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping smoking. it should be used as part of a behavioural support programme.

NICORETTE nicotine 4 mg (as nicotine Polacrilex) icy mint flavour chewing gum pocket pack Australia - English - Department of Health (Therapeutic Goods Administration)

nicorette nicotine 4 mg (as nicotine polacrilex) icy mint flavour chewing gum pocket pack

johnson & johnson pacific pty ltd - nicotine polacrilex, quantity: 20 mg - gum, chewing - excipient ingredients: peppermint oil; titanium dioxide; sucralose; carnauba wax; pregelatinised maize starch; hypromellose; acesulfame potassium; quinoline yellow aluminium lake; menthol; polysorbate 80; xylitol; light magnesium oxide; sodium carbonate; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; flavour - for the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitating smoking cessation in smokers,motivated to quit. in smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy,as a step towards stopping completely.

NICOTINE POLACRILEX lozenge United States - English - NLM (National Library of Medicine)

nicotine polacrilex lozenge

bryant ranch prepack - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid - reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

NICOTINE POLACRILEX lozenge United States - English - NLM (National Library of Medicine)

nicotine polacrilex lozenge

bryant ranch prepack - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid - reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking

NICOTINELL LOZENGES 2 MG Israel - English - Ministry of Health

nicotinell lozenges 2 mg

gsk consumer healthcare, israel ltd - nicotine - lozenges - nicotine 2 mg - nicotine - nicotine - an aid to smoking cessation, relief of symptoms associated with nicotine withdrawal.in smokers currently unable or not ready to stop smoking abruptly the lozenges may also be used as part of a program to reduce smoking prior to stopping completely.

NICOTINELL LOZENGES 2 MG Israel - English - Ministry of Health

nicotinell lozenges 2 mg

gsk consumer healthcare, israel ltd - nicotine - lozenges - nicotine 2 mg - nicotine - nicotine - an aid to smoking cessation, relief of symptoms associated with nicotine withdrawal.in smokers currently unable or not ready to stop smoking abruptly the lozenges may also be used as part of a program to reduce smoking prior to stopping completely.

NICOTINE POLACRILEX ORIGINAL FLAVOR- nicotine polacrilex gum, chewing
NICOTINE POLACRILEX ORIGIANL FLAVOR- nicotine polacrilex United States - English - NLM (National Library of Medicine)

nicotine polacrilex original flavor- nicotine polacrilex gum, chewing nicotine polacrilex origianl flavor- nicotine polacrilex

publix supermarkets, inc. - nicotine (unii: 6m3c89zy6r) (nicotine - unii:6m3c89zy6r) - stop smoking aid - reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking - a sodium-restricted diet - heart disease, recent heart attack, or irregular heartbeat. nicotine can increase your heart rate. - high blood pressure not controlled with medication. nicotine can increase blood pressure. - stomach ulcer or diabetes - history of seizures - using a non-nicotine stop smoking drug - taking prescription medicine for depression or asthma. your prescription dose may need to be adjusted.  - mouth, teeth, or jaw problems occur - irregular heartbeat or palpitations occur - you get symptoms of nicotine overdose such as nausea, vomiting, dizziness, diarrhea, weakness, and rapid heartbeat - you have symptoms of an allergic reaction (such as difficulty breathing or rash)